ATE295364T1 - Metallchelatverbindung, radiopharmazeutisches produkt, verfahren zu seiner herstellung und diagnose-kit - Google Patents

Metallchelatverbindung, radiopharmazeutisches produkt, verfahren zu seiner herstellung und diagnose-kit

Info

Publication number
ATE295364T1
ATE295364T1 AT01980839T AT01980839T ATE295364T1 AT E295364 T1 ATE295364 T1 AT E295364T1 AT 01980839 T AT01980839 T AT 01980839T AT 01980839 T AT01980839 T AT 01980839T AT E295364 T1 ATE295364 T1 AT E295364T1
Authority
AT
Austria
Prior art keywords
diagnostic kit
present
production
metal chelated
chelated compound
Prior art date
Application number
AT01980839T
Other languages
English (en)
Inventor
Laurent Mauclaire
Eric Berthommier
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of ATE295364T1 publication Critical patent/ATE295364T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/11—Compounds covalently bound to a solid support

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01980839T 2000-11-29 2001-11-12 Metallchelatverbindung, radiopharmazeutisches produkt, verfahren zu seiner herstellung und diagnose-kit ATE295364T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0015416A FR2817259B1 (fr) 2000-11-29 2000-11-29 Compose de chelation d'un metal, radiopharmaceutique, procede de fabrication de ceux-ci et trousse de diagnostic
PCT/IB2001/002141 WO2002044175A2 (en) 2000-11-29 2001-11-12 Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit

Publications (1)

Publication Number Publication Date
ATE295364T1 true ATE295364T1 (de) 2005-05-15

Family

ID=8857008

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01980839T ATE295364T1 (de) 2000-11-29 2001-11-12 Metallchelatverbindung, radiopharmazeutisches produkt, verfahren zu seiner herstellung und diagnose-kit

Country Status (9)

Country Link
US (1) US20040043920A1 (de)
EP (1) EP1337532B1 (de)
JP (1) JP2004514721A (de)
AT (1) ATE295364T1 (de)
AU (1) AU2002212623A1 (de)
DE (1) DE60110826D1 (de)
FR (1) FR2817259B1 (de)
NO (1) NO20032426L (de)
WO (1) WO2002044175A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1654005A4 (de) * 2003-07-24 2011-06-15 Bracco Imaging Spa Stabile radiopharmazeutische zusammensetzungen und herstellungsverfahren
MXPA06007059A (es) * 2003-12-22 2006-08-23 Astellas Pharma Inc Derivados de ornitina como agonistas o antagonistas de prostaglandina e2.
CN105949100B (zh) * 2016-05-18 2017-12-19 浙江云涛生物技术股份有限公司 新型二硫代氨基甲酸盐类重金属螯合剂的生产工艺
CN106588729B (zh) * 2016-12-06 2021-05-28 青岛柏森环保工程有限公司 一种多硫代酰肼型重金属螯合剂的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241963B1 (en) * 1995-10-19 2001-06-05 The Trustees Of The University Of Pennsylvania Dopamine and serotonin transporter ligands and imaging agents

Also Published As

Publication number Publication date
NO20032426D0 (no) 2003-05-28
WO2002044175A2 (en) 2002-06-06
EP1337532B1 (de) 2005-05-11
DE60110826D1 (de) 2005-06-16
WO2002044175A3 (en) 2002-08-15
NO20032426L (no) 2003-05-28
AU2002212623A1 (en) 2002-06-11
FR2817259B1 (fr) 2003-02-21
US20040043920A1 (en) 2004-03-04
EP1337532A2 (de) 2003-08-27
FR2817259A1 (fr) 2002-05-31
JP2004514721A (ja) 2004-05-20

Similar Documents

Publication Publication Date Title
ATE423130T1 (de) Deuterierte cyclosporin-analoga und ihre verwendung als immunmodulierende agenzien
IL172403A (en) D-amino acid peptides
ATE481987T1 (de) Verfahren zur radiofluoridierung von biologisch aktiven vektoren
MY110526A (en) Thioether conjugates
NZ296479A (en) Amino acid or peptide derivatives which are inhibitors of multicatalytic protease (mcp)
PL369119A1 (en) Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer
TNSN04017A1 (en) N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
MXPA04000328A (es) Derivados de alfa-hidroxiamida estatina para tratamiento de enfermedad de alzheimer.
MX338829B (es) Metodo para preparar 3-halo-4,5-dihidro-1h-pirazoles.
CA2457584A1 (en) Enhancing solubility of iron amino acid chelates and iron proteinates
MXPA04002785A (es) Aminas sustituidas para tratamiento de enfermedad de alzheimer.
ATE32728T1 (de) Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel.
ATE176904T1 (de) Verfahren zur herstellung von phenylalanin- derivaten oder homologen, die eine guanidin- oder modifizierte guanidin-gruppe enthalten, verwendbar für die herstellung von gnrh antagonistisch wirksamen peptiden
Altenburger et al. General synthesis of polyfunctionalized fluoromethyleneketone retroamides as potential inhibitors of thrombin
ATE323084T1 (de) Für die behandlung von alzheimer krankheit geeignete makrocyclen
DK1057826T3 (da) Substituerede dimere carboxamidforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
ATE295364T1 (de) Metallchelatverbindung, radiopharmazeutisches produkt, verfahren zu seiner herstellung und diagnose-kit
WO2002024213A3 (en) Improved protocol for paracentesis
WO2003080631A3 (en) Plasma carboxypeptidase b inhibitors
EA200200807A1 (ru) Аминокислотные соединения и их применение в качестве ингибиторов nep, ace и ece
ATE83242T1 (de) Cysteinreiche, gamma-glutaminsaeure und betaalanin-einheitenaufweisende peptide, verfahren zu deren herstellung und ihre verwendung.
DE68923592T2 (de) HIV Protease-Hemmer.
GEP20074100B (en) Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising the same
ATE405827T1 (de) Screening-verfahren
JPH01128999A (ja) オクタペプチドの溶液合成

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties